Asia-Pacific nutritional supplements market will grow at a 2019-2026 CAGR of 11.3% and become the largest regional market with a share of 30.44% in global scenario by 2026.
Highlighted with 36 tables and 57 figures, this 133-page report “Asia-Pacific Nutritional Supplements Market by Ingredient, Product Form, Application, End-user, Supplement Classification, Distribution Channel, and Country 2019-2026: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia-Pacific nutritional supplements market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report provides historical market data for 2015-2018, revenue estimates for 2019, and forecasts from 2020 till 2026. (Please note: The report will be updated before delivery if necessary, so that the latest historical year is the base year and the forecast covers the next 5-10 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia-Pacific market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify Asia-Pacific nutritional supplements market in every aspect of the classification from perspectives of Ingredient, Product Form, Application, End-user, Supplement Classification, Distribution Channel, and Country.
Based on ingredient, the Asia-Pacific market is segmented into the following sub-markets with annual capex for 2015-2026 (historical and forecast) included in each section.
• Botanicals
• Vitamins
• Minerals
• Proteins & Amino Acids
• Fish Oils
• Fibers & Specialty Carbohydrates
• Enzymes
• Others
Based on product form, the Asia-Pacific market is segmented into the following sub-markets with annual capex for 2015-2026 (historical and forecast) included in each segment.
• Tablets
• Capsules
• Powder
• Liquids
• Soft Gels & Gel Caps
• Gummies
• Others
Based on application, the Asia-Pacific market is analyzed on the following segments with annual capex for 2015-2026 (historical and forecast) included in each section.
• Additional Supplements
• Medicinal Supplements
• Sports Nutrition
Based on end-user, the Asia-Pacific market is segmented into the following sub-markets with annual capex for 2015-2026 (historical and forecast) included in each section.
• Infant
• Children
• Adults
• Pregnant Women
• Elderly
Based on classification, the Asia-Pacific market is segmented into the following sub-markets with annual capex for 2015-2026 (historical and forecast) included in each segment.
• OTC
• Prescription
Based on distribution channel, the Asia-Pacific market is analyzed on the following segments with annual capex for 2015-2026 (historical and forecast) included in each section.
• Retail Stores & Hospitals
• Supermarkets & Hypermarkets
• Online Stores
• Others
Geographically, the following national markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC
For each of the aforementioned countries, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of key national markets by Ingredient, Product Form, Application, End-user, and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Asia-Pacific nutritional supplements market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players:
Abbott Laboratories
ADM
American Health
Amway Corporation
Archer Daniels Midland Company
Arkopharma Laboratoires Pharmaceutiques
Ayanda
Bayer
Bionova Lifesciences
Carlyle Group
DuPont
DSM
Ekomir
Glanbia Nutritionals
GlaxoSmithKline
Herbalife International
Himalaya Asia-Pacific Holdings Ltd.
Nature’s Sunshine Products
Nestle Nutritionals
NBTY, Inc.
Pfizer Inc.
Stepan
XanGo
(Please note: The report will be updated before delivery if necessary, so that the latest historical year is the base year and the forecast covers the next 5-10 years over the base year.)